BAX DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX
08. September 2023 21:12 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 25, 2022...
ROSEN, A LEADING LAW FIRM, Encourages Baxter International Inc. Investors With Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX
03. September 2023 11:31 ET
|
The Rosen Law Firm PA
NEW YORK, Sept. 03, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
28. August 2023 20:27 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022 and...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
23. August 2023 19:08 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX
13. August 2023 08:52 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 13, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
08. August 2023 13:33 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 08, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
28. Juli 2023 20:59 ET
|
The Rosen Law Firm PA
NEW YORK, July 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
23. Juli 2023 12:06 ET
|
The Rosen Law Firm PA
NEW YORK, July 23, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baxter International Inc. (NYSE: BAX) between May 12, 2022 and...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – BAX
17. Juli 2023 20:00 ET
|
The Rosen Law Firm PA
NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Baxter...
Corbus Pharmaceuticals Appoints Rachelle Jacques to Board of Directors
08. April 2019 08:05 ET
|
Corbus Pharmaceuticals Holdings, Inc.
Appointment brings global commercialization and marketing experience for rare diseases to the Board of Directors Appointment aligns with Company’s vision to become the leader in the treatment of...